The Resistant Depression Response to Esketamine Assessing Metabolomics (ReDREAM) Project— Untargeted Metabolomics to Identify Biomarkers of Treatment Response to Intranasal Esketamine in Individuals with Treatment-Resistant Depression: A Study Protocol.
Autor: | Bartoli, Francesco1, Cavaleri, Daniele1 d.cavaleri1@campus.unimib.it, Riboldi, Ilaria1, Crocamo, Cristina1, de Filippis, Renato2, Callegher, Riccardo Zandonella3, Paglia, Giuseppe1, Albert, Umberto3, De Fazio, Pasquale2, Carrà, Giuseppe1 |
---|---|
Zdroj: | Alpha Psychiatry. Aug2024, Vol. 25 Issue 4, p555-560. 6p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |